Biology · 12th Grade · Information Storage and Transfer · Weeks 10-18

Bioethics of Genetic Technologies

Discuss the societal and ethical implications of genetic technologies, including privacy and access.

• Common Core State Standards
• HS-LS3-1
• HS-ETS1-3

About This Topic

Genetic technologies including whole-genome sequencing, CRISPR editing, direct-to-consumer testing, and gene patents raise policy and ethical questions that science alone cannot answer. These technologies generate data about individuals, families, and populations, with implications for medical insurance, employment, reproductive choices, and criminal justice. The Genetic Information Nondiscrimination Act (GINA) offers partial federal protections in the US, but gaps in coverage for life and disability insurance remain significant.

In the 12th-grade US biology curriculum, this topic addresses NGSS HS-LS3-1 and HS-ETS1-3 by asking students to reason about trade-offs between scientific capability and societal benefit. Students examine who holds genetic data, who profits from it, who consents to its use, and how access to genetic medicine is distributed across socioeconomic lines. Direct-to-consumer testing companies have shared customer data with pharmaceutical firms, raising questions students will encounter as adults and citizens.

Active learning is essential for this topic because the core task is reasoning under genuine uncertainty, not recalling established facts. Structured debates, stakeholder simulations, and policy analysis exercises prepare students to participate in real civic conversations about genetic technology governance.

Key Questions

1. Justify whether private companies should have the right to patent naturally occurring genetic sequences.
2. Critique the ethical considerations surrounding genetic privacy and data sharing.
3. Assess the potential for genetic technologies to exacerbate or alleviate social inequalities.

Learning Objectives

• Critique the ethical arguments for and against patenting naturally occurring genetic sequences.
• Analyze the potential consequences of genetic data sharing on individual privacy and societal equity.
• Evaluate the role of genetic technologies in potentially widening or narrowing socioeconomic disparities.
• Synthesize information from scientific articles and policy briefs to propose guidelines for responsible genetic data management.

Before You Start

Mendelian Genetics and Inheritance Patterns

Why: Students need a foundational understanding of genes, alleles, and how traits are inherited to grasp the implications of genetic technologies.

DNA Structure and Function

Why: Knowledge of DNA's role as the blueprint of life is essential for understanding gene sequencing and editing.

Introduction to Biotechnology

Why: Prior exposure to basic biotechnological tools and concepts provides context for discussing advanced genetic technologies.

Key Vocabulary

Gene Patenting	The legal protection granted to individuals or companies for naturally occurring gene sequences, allowing them exclusive rights to use, sell, or modify them.
Genetic Privacy	The right of individuals to control access to and use of their personal genetic information, including DNA sequences and related health data.
CRISPR	A revolutionary gene-editing technology that allows scientists to precisely modify DNA sequences, raising ethical questions about its application in humans.
Direct-to-Consumer (DTC) Genetic Testing	Services offered directly to consumers that provide analysis of their DNA, often for ancestry, health predispositions, or traits, without involving a healthcare provider.
Genetic Discrimination	The unfair treatment of individuals based on their genetic makeup, potentially affecting insurance, employment, or other opportunities.

Watch Out for These Misconceptions

Common Misconception

Bioethics means having an opinion, so any answer to an ethical question is equally valid.

What to Teach Instead

Bioethical reasoning requires evidence, logical consistency, and engagement with competing values. Active discussion formats help students see that some positions are better supported by evidence and more coherent than others, even when reasonable people continue to disagree.

Common Misconception

GINA fully protects Americans from all forms of genetic discrimination.

What to Teach Instead

GINA prohibits discrimination in health insurance and employment but does not cover life insurance, disability insurance, or long-term care insurance. Students are often surprised by these gaps, which reinforces the importance of examining what laws actually say rather than assuming protection is comprehensive.

Common Misconception

Genetic privacy is mainly an individual concern about keeping personal secrets.

What to Teach Instead

Genetic data reveals information about biological relatives who never consented to testing and can reveal population-level patterns used to make assumptions about ethnic groups. Understanding this collective dimension is important when evaluating data-sharing policies and their potential harms.

Active Learning Ideas

Formal Debate: Should Genetic Sequences Be Patentable?

Divide students into groups representing a biotech company, a patient advocacy organization, and a research university. Each group prepares a 3-minute position statement on gene patenting, then the class holds a structured debate. Afterward, students discuss which arguments they found most persuasive and why, separating scientific from economic from ethical reasoning.

45 min·Small Groups

Stakeholder Role-Play: Genetic Privacy Policy Council

Assign roles including insurance company representative, genetic counselor, civil liberties advocate, and rural patient without insurance to debate a proposed state law requiring genetic testing results to be shared with insurers. After the simulation, students reflect in writing on which considerations changed their thinking.

40 min·Small Groups

Case Analysis: Direct-to-Consumer Genetic Testing Policies

Students read a brief summary of a DTC testing company's privacy policy and data-sharing agreements. In pairs, they identify what a consumer consents to, what is unclear, and what they think should be regulated differently. Each pair drafts a one-paragraph consumer protection recommendation.

30 min·Pairs

Gallery Walk: Genetic Technology and Social Inequality

Post five stations presenting scenarios where genetic technology intersects with social inequality, including prenatal testing access, pharmacogenomics and race, and genetic ancestry in immigration enforcement. Students leave sticky notes noting the ethical issue and a possible policy response at each station.

30 min·Whole Class

Real-World Connections

• Patients undergoing genetic testing at companies like 23andMe or AncestryDNA may have their anonymized data used by pharmaceutical companies for drug discovery, raising questions about consent and profit.
• The legal battles over patenting genes, such as the Myriad Genetics case involving BRCA genes, highlight the complex intersection of intellectual property law and genetic information.
• Advocacy groups like the Future of Privacy Forum work to inform policymakers and the public about the implications of genetic data use for insurance and employment, referencing laws like GINA.

Assessment Ideas

Discussion Prompt

Pose the question: 'Should a private company have the right to patent a gene sequence found in nature?' Ask students to take a stance and support it with at least two ethical or economic arguments, considering the perspectives of patients, researchers, and the company.

Exit Ticket

On an index card, have students write one potential benefit and one potential risk of sharing genetic data with third-party researchers. Ask them to identify one specific group that might be negatively impacted by genetic data sharing.

Quick Check

Present a short scenario: 'A direct-to-consumer genetic testing company sells anonymized user data to a pharmaceutical firm developing a new cancer drug.' Ask students to write one sentence explaining how this scenario relates to the concept of genetic privacy and one sentence on how it might affect social equity.

Frequently Asked Questions

Can a company legally patent human genes in the United States?

The Supreme Court ruled in Association for Molecular Pathology v. Myriad Genetics (2013) that naturally occurring DNA sequences cannot be patented. However, complementary DNA (cDNA) synthesized in a lab can still be patented. This distinction affects how researchers access genetic tools and how much patients pay for diagnostic tests.

What is genetic discrimination and what US laws protect against it?

Genetic discrimination means treating someone unfairly based on genetic test results or predispositions. In the US, GINA (2008) prohibits health insurers and employers from using genetic information in coverage or hiring decisions. However, life insurance, disability insurance, and long-term care insurance are not covered, leaving significant gaps in protection.

Who owns the genetic data collected by direct-to-consumer testing companies?

Ownership and usage rights are defined in terms of service agreements that few consumers read carefully. Most major DTC companies can share de-identified data with research partners; some have sold access to pharmaceutical companies. Users can often opt out of research sharing, but data already shared cannot be retrieved.

How does active learning prepare students to engage with genetic bioethics debates?

Classroom simulations of policy councils, structured debates, and stakeholder role-plays put students in the position of making real decisions with incomplete information, exactly the situation policymakers and citizens face. This practice builds the capacity to evaluate competing claims rather than simply react to headlines about new genetic technologies.